KU patient's case highlights risk of tainted platelets
For the second time in three years, a University of Kansas Hospital cancer patient has received tainted platelets from the Community Blood Center. In the first case, the patient died within 48 hours after receiving a transfusion laced with E. coli bacteria. In the second instance, which occurred Oct. 13, the patient spent days on a respirator and nearly died. The FDA's regional office visited KU's blood bank last week and has reviewed the Community Blood Center's policies. KU's transfusion committee also will review the hospital’s platelet safety procedures. The hospital will bring in national experts to review its blood safety policies.
- Sharp HealthCare Leaves Pioneer ACO Program
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Interventional Radiology No Longer a Sub-Specialty
- MA an Insurance Proving Ground for Providers
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Targeting Self-Insured Populations
- mHealth Tackles Readmissions
- States Without Medicaid Expansion Search for Alternatives